Clinical trial
Analysis of Circulating MYCN DNA in Serum Samples Obtained From Patients With Neuroblastoma
NCT00898391 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Circulating MYCN DNA in Serum Samples Obtained From Patients With Neuroblastoma
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- May 31, 2016
- Enrollment
- 329 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disseminated neuroblastoma, localized resectable neuroblastoma, localized unresectable neuroblastoma, recurrent neuroblastoma, regional neuroblastoma, stage 4s neuroblastoma